Dr. Amruta Beke
Specialist, Onco Sciences
Nationality
Language
Experience
: Indian
: English , Hindi , Marathi
: 20 Years
About Dr. Amruta Beke
for her expertise in diagnosing and treating various types of cancers with precision and compassion. With a strong academic background and advanced surgical training, she brings a patient-centric approach to oncology care.
Dr. Beke holds prestigious qualifications including MBBS, DNB, and MCh in Oncology, reflecting her commitment to excellence in cancer treatment and continuous medical advancement. She specializes in managing complex oncological cases, offering both surgical and multidisciplinary treatment strategies tailored to each patient’s unique condition.
At VishwaRaj Hospital, she is recognized for her empathetic communication style and her ability to guide patients and families through every stage of cancer care—from diagnosis to recovery. Her approach combines cutting-edge surgical techniques with evidence-based oncology practices to ensure optimal outcomes.
Dr. Beke is particularly focused on early detection, minimally invasive cancer surgeries, and comprehensive cancer management, aiming to improve survival rates and enhance quality of life for her patients.
Areas of Expertise
Dr. Amruta specializes in the surgical management of various benign and malignant conditions, including:
- Lung Cancer Surgery
- Gastrointestinal Cancer Surgery
- Breast Cancer Surgery
- Bone and Soft Tissue Tumor Surgery
- Omentectomy
- Head & Neck Cancer Surgery
- Commando Surgery (Composite Resection for Oral Cancers)
Frequently Asked Questions
What are the early signs of cancer?
Early symptoms vary but may include unexplained weight loss, persistent fatigue, lumps, changes in skin, unusual bleeding, or chronic pain. Early detection significantly improves outcomes.
What causes cancer?
Cancer is caused by genetic mutations due to factors like tobacco use, infections, radiation exposure, unhealthy diet, lack of exercise, and environmental toxins.
Can cancer be cured?
Many cancers are curable if detected early. Advances in surgery, chemotherapy, immunotherapy, and targeted therapy have significantly improved survival rates.